NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1144486945 M.D.
Verify on CMS → Samer Hafi, M.D.
Endocrinology, Diabetes & Metabolism Physician in Issaquah, Washington.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
5K
Medicare Part D claims · 503 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
48%
generic claims · 47% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.8/100
▼ 0 pts below national avg 83.1 · Above neutral
Industry payments
$15.91
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Samer Hafi, M.D. reported a CMS MIPS final score of 82.8/100 - below the 83.1 national average - and filed 5,282 Medicare Part D claims in 2023.
- 82.8/100
- MIPS score · 0 vs avg
- 5K
- Part D claims, 2023
- 48%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Samer Hafi, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
83 39th percentile higher than 39% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Samer Hafi, M.D. sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,521 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Samer Hafi, M.D. writes more Part D claims than 82% of them and scores higher on MIPS quality than 44% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Samer Hafi, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Samer Hafi, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Samer Hafi, M.D.?
Near national averagePrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
5,282 100% vs specialty avg
MIPS final score
82.8/100 0.3 pts vs avg
Specialty distribution in Washington
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Washington providers
Medicare quality performance, MIPS
Samer Hafi, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 82.8/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 82.8/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Samer Hafi, M.D. appears in the CMS NPPES registry as an Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 751 NE BLAKELY DR STE 5010, Issaquah, WA, 98029, with a listed phone of (425) 313-7757. NPI 1144486945 was issued on 07/31/2008.
Medicare Part D records for calendar year 2023 show 5,282 prescription claims written by this provider, covering 503 Medicare beneficiaries and totaling roughly $2.5 million in drug spend, split 47% brand-name and 48% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.8/100 for the 2023 performance year (Quality 82.1, Cost 60.7), compared with the national average of 83.1.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,871 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1144486945 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/31/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
82.8417
Final Score
Avg: 83.1
82.1476
Quality
60.658
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Samer Hafi, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Swedish Health Services
Issaquah, WA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Samer Hafi, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$16
Largest payer
SANOFI-AVENTIS U.S. LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Washington WMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 - they are NOT specific to Samer Hafi, M.D.. To verify Samer Hafi, M.D.'s current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases
WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Samer Hafi, M.D. - brand share 47.0%
Endocrinology, Diabetes & Metabolism Physician average
47% brand-name claims vs 48% generic, on 5,282 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
5,282
Total Claims
$2.5M
Total Drug Cost
503
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 11,134
- Total Day Supply
- 330,790
- Brand vs Generic
- 47% brand / 48% generic
- Brand Drug Cost
- $2.3M
- Generic Drug Cost
- $96K
Patient Demographics
- Average Patient Age
- 72.0 years
- Avg HCC Risk Score
- 1.52
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 54, 65-74: 250, 75-84: 164, 85+: 35
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Samer Hafi, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Repaglinide
Repaglinide
516 claims
- Ozempic
Ozempic
479 claims
- Levothyroxine Sodium
Levothyroxine Sodium
421 claims
- Metformin Hcl Er
Metformin Hcl Er
357 claims
- Jardiance
Jardiance
295 claims
- Metformin Hcl
Metformin Hcl
229 claims
- Acarbose 199
Acarbose
199 claims
- Methimazole 139
Methimazole
139 claims
| Drug | Claims |
|---|---|
| Repaglinide | 516 |
| Ozempic Semaglutide | 479 |
| Levothyroxine Sodium | 421 |
| Metformin Hcl Er Metformin Hcl | 357 |
| Jardiance Empagliflozin | 295 |
| Metformin Hcl | 229 |
| Acarbose | 199 |
| Methimazole | 139 |
| Liothyronine Sodium | 126 |
| Humalog Kwikpen U-100 Insulin Lispro | 109 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in WA →
All providers in Washington →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Samer Hafi, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Samer Hafi, M.D.'s 5,282 claims are above the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Washington
Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as Hafi.
Dr. Rtika Abraham
MD
Issaquah, WA
Sonia Afshariyamchlou
Richland, WA
Dr. Iram Ahmad
M.D.
Seattle, WA
Dr. Mandana Ahmadian
MD
Bellevue, WA
Dr. Anam Akmal
M.D
Lacey, WA
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Washington medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Washington
Frequently Asked Questions
What is Samer Hafi, M.D.'s specialty? ▼
Samer Hafi, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Issaquah, Washington. Credentials: M.D..
How much does Samer Hafi, M.D. prescribe under Medicare Part D? ▼
In 2023, Samer Hafi, M.D. wrote 5,282 Medicare Part D claims totaling $2.5M in drug costs for 503 beneficiaries.
What is Samer Hafi, M.D.'s Medicare quality score? ▼
Samer Hafi, M.D. has a CMS MIPS Final Score of 82.8/100 (Quality: 82.1, Cost: 60.7). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Samer Hafi, M.D. located? ▼
Samer Hafi, M.D. is located at 751 NE BLAKELY DR STE 5010, Issaquah, WA, 98029. Phone: (425) 313-7757.
What is Samer Hafi, M.D.'s NPI number? ▼
Samer Hafi, M.D.'s National Provider Identifier (NPI) is 1144486945, issued on 07/31/2008.
Does Samer Hafi, M.D. prescribe more brand-name or generic drugs? ▼
Samer Hafi, M.D.'s prescribing is 47% brand-name and 48% generic drugs by claim count, with $2.3M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Samer Hafi, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Samer Hafi, M.D.'s most frequently prescribed drugs include Repaglinide, Ozempic, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Samer Hafi, M.D. accept Medicare? ▼
Samer Hafi, M.D. appears in CMS Medicare data with 5,282 Part D claims and 503 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Samer Hafi, M.D.'s credentials? ▼
Samer Hafi, M.D.'s NPI is 1144486945 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.